The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
MJFF Research Grant, 2010Generating and Characterizing LRRK2 Antibodies
Objective/Rationale:
LRRK2 is a gene implicated in the development of some familial Parkinson’s disease cases. Because of LRRK2’s significant potential as a drug target, MJFF is making considerable... -
MJFF Research Grant, 2010Comparison and Actions of MANF and GDNF in Rodent Models of Parkinson's Disease
Objective/Rationale:
Parkinson's disease (PD) is caused by the degeneration of certain dopaminergic neurons in the brain. Neurotrophic factors like GDNF protect dopaminergic neurons from degenerating... -
MJFF Research Grant, 2010Viral Over-expression of Alpha Synuclein
Promising Outcomes of Original Grant:
In our previous grant, we attempted to create a bilateral model of PD using viral over expression of alpha-synuclein. The performance of the study was near... -
MJFF Research Grant, 2010A Rodent Model of Pathological Gambling Associated with Medicated Parkinsonian Patients
Promising Outcomes of Original Grant:
In keeping with our original hypothesis, we determined the following: 1) Being in a parkinsonian state (i.e., following 6-OHDA-induced lesions) alters impulsivity... -
Improving Delivery of Parkinson's Disease Therapeutics to th, 2010Novel Antibodies for the Delivery of Parkinson's Therapeutics
Promising Outcomes of Original Grant:
The initial granting period resulted in the successful identification of antibodies capable of targeting and internalizing into novel in vitro blood-brain barrier... -
Target Validation, 2010Validation of VPS41, a Protein Involved in Lysosomal Trafficking, as a Target for Parkinson Disease Therapy
Promising Outcomes of Original Grant:
VPS41 was identified in a C. elegans system. In the original funded grant, we demonstrated that human VPS41 (hVPS41) was also protective in C. elegans, performed a...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.